Partial response to first generation SSA guides the choice and predict the outcome of second line therapy in acromegaly.

导出 OA

翻译打印收藏纠错

第一作者： Sabrina,Chiloiro

第一单位： Department of Translational Medicine and Surgery, Università Cattolica del Sacro Cuore, 00168, Roma, Italy.;UOC Endocrinology and Diabetology, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168, Roma, Italy.

作者： Sabrina,Chiloiro ^[1] ; Denise,Costa ^[2] ; Rosa,Lauretta ^[3] ; Valeria,Mercuri ^[2] ; Emilia,Sbardella ^[2] ; Irene,Samperi ^[4] ; Marialuisa,Appetecchia ^[3] ; Antonio,Bianchi ^[1] ; Antonella,Giampietro ^[1] ; Patrizia,Gargiulo ^[2] ; Andrea M,Isidori ^[2] ; Maurizio,Poggi ^[4] ; Alfredo,Pontecorvi ^[1] ; Laura,De Marinis ^[5]

作者单位： Department of Translational Medicine and Surgery, Università Cattolica del Sacro Cuore, 00168, Roma, Italy.;UOC Endocrinology and Diabetology, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168, Roma, Italy. ^[1] Department of Experimental Medicine, Endocrinology-Pituitary Disease, "Sapienza" University of Rome, Roma, Italy. ^[2] Oncological Endocrinology Unit, IRCCS Regina Elena National Cancer Institute, Roma, Italy. ^[3] Endocrine-Metabolic Unit, Sant'Andrea University Hospital, Rome, Italy. ^[4] Department of Translational Medicine and Surgery, Università Cattolica del Sacro Cuore, 00168, Roma, Italy. laura.demarinis@unicatt.it.;UOC Endocrinology and Diabetology, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168, Roma, Italy. laura.demarinis@unicatt.it. ^[5]

关键词 GH GH secreting pituitary adenoma Growth hormone IGF-I Pasireotide Pegvisomant